Table 1.
Authors and reference nos. | Achievements |
---|---|
Osathanondh and Potter4, 5, 6, 7 | Microdissection studies of normal and malformed human embryonic kidneys |
Keller et al.8 | Counting glomeruli in human kidneys |
Grobstein9 | Organ culture of embryonic mouse kidneys |
Klein et al.10 | Manipulating mouse kidney development in organ culture by targeting a specific protein |
Lindström et al.11, 12, 13 | Morphologic and molecular comparisons of human and mouse native developing kidneys |
Taguchi et al.14; Taguchi and Nishinakamura15 | Definition of growth factors and other molecules that pattern intermediate mesoderm to form the metanephric mesenchyme or the ureteric bud |
Taguchi and Nishinakamura15; Takasato et al.16; Lam et al.17; Morizane et al.18 |
Defining in vitro protocols to drive hPSCs to kidney precursor cells |
Takasato et al.19; Morizane and Bonventre20; Hale et al.21; Wu et al.22 | Generating 3D kidney organoids from hPSCs and detailed molecular profiling of these tissues |
Bantounas et al.23; van den Berg et al.24; Homan et al.25 | Enhancing glomerular vascularization and maturation of glomerular basement membrane using in vivo implants or perfusion in culture |
Freedman et al.26; Benedetti et al.27; Czerniecki et al.28 | Using hPSC-derived kidney structures to model genetic kidney disease and test drug therapies |
hPSC, human pluripotent stem cell; 3D, 3-dimensional.
Underpinning historical reports using native kidneys, as well as more recent studies using kidney tissues derived from pluripotent stem cells. The list is not exhaustive.